Tag: U-ACHIEVE

Upadacitinib associated with normalisation of HRQoL in UC

Presented By
Dr Joana Torres, Hospital Beatriz Ângelo, Portugal
Trial
U-ACHIEVE; U-ACCOMPLISH
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:21

ECCO 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ECCO 2022

8 March 2022 10:18

Upadacitinib efficacious and safe as maintenance therapy for UC

Presented By
Dr Remo Panaccione, University of Calgary, Canada
Trial
Phase 3, U-ACHIEVE, U-ACCOMPLISH
Conference
UEGW 2021
Type
News article

27 October 2021 10:06

Upadacitinib outperforms placebo in UC patients with inadequate response to biologics

Presented By
Prof. Séverine Vermeire, University Hospital Leuven, Belgium
Trial
Phase 3, U-ACHIEVE, U-ACCOMPLISH
Conference
UEGW 2021
Type
News article

27 October 2021 10:02

Rapid symptom control for UC patients on upadacitinib

Presented By
Dr Edward Loftus Jr, Mayo Clinic College of Medicine, MN, USA
Trial
Phase 3, U-ACHIEVE, U-ACCOMPLISH
Conference
UEGW 2021
Type
News article

27 October 2021 10:01

Upadacitinib meets primary endpoint for moderate-to-severe UC

Presented By
Dr Séverine Vermeire, University hospital Leuven, Belgium
Trial
Phase 3, U-ACCOMPLISH
Conference
ECCO 2021
Type
News article

2 July 2021 23:34

Clinical remission after dose escalation of upadacitinib

Presented By
Dr W. Sandborn & Dr S. Vermeire
Trial
Phase 2, CELEST, U-ACHIEVE
Conference
ECCO 2020
Type
Peer-reviewed article

14 April 2020 12:45

Upadacitinib: data from U-ACHIEVE and CELEST

Trial
U-ACHIEVE and CELEST
Conference
ECCO 2019
Type
Peer-reviewed article

9 May 2019 17:48
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com